Novavax (NVAX) Stock Statistics & Valuation Metrics
Total Valuation
Novavax has a market cap or net worth of MXN 31.23B. The enterprise value is MXN 1.13B.
- Market Cap
- MXN 31.23B
- Enterprise Value
- MXN 1.13B
Share Statistics
Novavax has 164,945,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 164,945,720
- Owned by Insiders
- 0.58%
- Owned by Institutions
- 8.36%
Financial Efficiency
Novavax’s return on equity (ROE) is -3.45 and return on invested capital (ROIC) is 78.00%.
- Return on Equity (ROE)
- -3.45
- Return on Assets (ROA)
- 0.37
- Return on Invested Capital (ROIC)
- 78.00%
- Return on Capital Employed (ROCE)
- 0.79
- Revenue Per Employee
- 1.50M
- Profits Per Employee
- 587.85K
- Employee Count
- 749
- Asset Turnover
- 0.95
- Inventory Turnover
- 6.16
Valuation Ratios
The current PE Ratio of Novavax is -6.63. Novavax’s PEG ratio is 0.08.
- PE Ratio
- -6.63
- PS Ratio
- 4.02
- PB Ratio
- -8.70
- Price to FCF
- -38.14
- Price to Operating Cash Flow
- -42.00
- PEG Ratio
- 0.08
Income Statement
In the last 12 months, Novavax had revenue of 1.12B and earned 440.30M in profits. Earnings per share was 2.72.
- Revenue
- 1.12B
- Gross Profit
- 1.05B
- Operating Income
- 563.27M
- Pretax Income
- 442.17M
- Net Income
- 440.30M
- EBITDA
- 492.33M
- Earnings Per Share (EPS)
- 2.72
Cash Flow
In the last 12 months, operating cash flow was -39.50M and capital expenditures -4.09M, giving a free cash flow of -43.59M billion.
- Operating Cash Flow
- -39.50M
- Free Cash Flow
- -43.59M
- Free Cash Flow per Share
- -0.26
Dividends & Yields
Novavax pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.62%
- Earnings Yield
- -14.93%
Stock Price Statistics
- Beta
- 0.84
- 52-Week Price Change
- 21.81%
- 50-Day Moving Average
- 185.11
- 200-Day Moving Average
- 162.88
- Relative Strength Index (RSI)
- 47.30
- Average Volume (3m)
- 1,173
Important Dates
Novavax upcoming earnings date is Nov 05, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Novavax as a current ratio of 2.13, with Debt / Equity ratio of -194.76%
- Current Ratio
- 2.13
- Quick Ratio
- 2.10
- Debt to Market Cap
- 0.22
- Net Debt to EBITDA
- 0.02
- Interest Coverage Ratio
- 24.98
Taxes
In the past 12 months, Novavax has paid 1.86M in taxes.
- Income Tax
- 1.86M
- Effective Tax Rate
- 0.00
Enterprise Valuation
Novavax EV to EBITDA ratio is -8.59, with an EV/FCF ratio of -40.53.
- EV to Sales
- 4.27
- EV to EBITDA
- -8.59
- EV to Free Cash Flow
- -40.53
- EV to Operating Cash Flow
- -44.73
Balance Sheet
Novavax has MXN 719.34M in cash and marketable securities with MXN 295.60M in debt, giving a net cash position of MXN 423.74M billion.
- Cash & Marketable Securities
- MXN 719.34M
- Total Debt
- MXN 295.60M
- Net Cash
- MXN 423.74M
- Net Cash Per Share
- MXN 2.57
- Tangible Book Value Per Share
- -MXN 1.84
Margins
Gross margin is 77.85%, with operating margin of -54.94%, and net profit margin of -59.87%.
- Gross Margin
- 77.85%
- Operating Margin
- -54.94%
- Pretax Margin
- -59.28%
- Net Profit Margin
- -59.87%
- EBITDA Margin
- -49.68%
- EBIT Margin
- -53.99%
Analyst Forecast
The average price target for Novavax is MXN 200.62, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- MXN 200.62
- Price Target Upside
- 6.15% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 4
- Revenue Growth Forecast
- -65.63%
- EPS Growth Forecast
- -151.64%
Scores
- Smart Score
- 6
- AI Score
- ―